Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Delisting notice
  2. 8-K Event Executive or director change
  3. 8-K Event Exit or restructuring costs
  4. 8-K Event Results of operations
  5. 8-K Event Results of operations
  6. 8-K Event Executive or director change
  7. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  8. 8-K Event Other events
  9. 8-K Event Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. 8-K Event Executive or director change · Bylaws or fiscal year change
  12. 8-K Event Results of operations
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement
  16. 8-K Event Results of operations
  17. 8-K Event Material agreement · Unregistered share sale
  18. 8-K Event Shareholder vote results
  19. 8-K Event Results of operations
  20. DEF 14A Proxy Proxy Statement

Page 2 of 8 · 158 filings